Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19

The contagiosity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has startled mankind and has brought our lives to a standstill. The treatment focused mainly on repurposed immunomodulatory and antiviral agents along with the availability of a few vaccines for prophylaxis to vanquish...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Heliyon
Main Authors: Jeyaraman, Madhan, Muthu, Sathish, Bapat, Asawari, Jain, Rashmi, Sushmitha, E.S., Gulati, Arun, Channaiah Anudeep, Talagavadi, Dilip, Shirodkar Jaswandi, Jha, Niraj Kumar, Kumar, Dhruv, Kesari, Kavindra Kumar, Ojha, Shreesh, Dholpuria, Sunny, Gupta, Gaurav, Dureja, Harish, Chellappan, Dinesh Kumar, Singh, Sachin Kumar, Dua, Kamal, Jha, Saurabh Kumar
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2021
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8294777/
https://ncbi.nlm.nih.gov/pubmed/34312598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2021.e07635
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados